Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Adam

Showing results (31-40 of 152) with videos related to

Pageof 16
Sort By:
Urologic Oncology|August 25, 2021
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UCMyriam Kossaï, Camélia Radulescu, Julien Adam, et al.
European Radiology|June 15, 2016
Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablationLambros Tselikas, Thierry de Baere, Frederic Deschamps, et al.
Critical Reviews in Oncology/Hematology|June 28, 2020
Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive reviewTarek Assi, Joseph Kattan, Elie Rassy, et al.
Molecular Diagnosis & Therapy|January 24, 2024
Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics AdvancesSoledad Iseas, Golubicki Mariano, Louis Gros, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2015
CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patientsFayçal Djenidi, Julien Adam, Aïcha Goubar, et al.
Oncotarget|October 21, 2016
A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancerAntonin Levy, Etienne Bardet, Benjamin Lacas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancerMathieu Rouanne, Reem Betari, Camélia Radulescu, et al.
Cancers|August 7, 2021
The Most Common <i>VHL</i> Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity RegulationStéphanie Buart, Stéphane Terry, M'boyba Khadija Diop, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2017
Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancerLinda Mahjoubi, Anas Gazzah, Aurélien Marabelle, et al.
Nature Communications|July 2, 2025
Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapiesIsabelle Damei, Aziza Caidi, Edouard Auclin, et al.
Pageof 16

Showing results (31-40 of 152) with videos related to

Sort By:
Pageof 16
Urologic Oncology|August 25, 2021
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UCMyriam Kossaï, Camélia Radulescu, Julien Adam, et al.
European Radiology|June 15, 2016
Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablationLambros Tselikas, Thierry de Baere, Frederic Deschamps, et al.
Critical Reviews in Oncology/Hematology|June 28, 2020
Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive reviewTarek Assi, Joseph Kattan, Elie Rassy, et al.
Molecular Diagnosis & Therapy|January 24, 2024
Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics AdvancesSoledad Iseas, Golubicki Mariano, Louis Gros, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2015
CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patientsFayçal Djenidi, Julien Adam, Aïcha Goubar, et al.
Oncotarget|October 21, 2016
A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancerAntonin Levy, Etienne Bardet, Benjamin Lacas, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancerMathieu Rouanne, Reem Betari, Camélia Radulescu, et al.
Cancers|August 7, 2021
The Most Common <i>VHL</i> Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity RegulationStéphanie Buart, Stéphane Terry, M'boyba Khadija Diop, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2017
Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancerLinda Mahjoubi, Anas Gazzah, Aurélien Marabelle, et al.
Nature Communications|July 2, 2025
Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapiesIsabelle Damei, Aziza Caidi, Edouard Auclin, et al.
Pageof 16